IL-10 and class 1 histone deacetylases act synergistically and independently on the secretion of proinflammatory mediators in alveolar macrophages

被引:21
作者
Stanfield, Brent A. [1 ,2 ,3 ]
Purves, Todd [1 ,2 ,4 ]
Palmer, Scott [1 ,5 ,6 ]
Sullenger, Bruce [1 ,2 ]
Welty-Wolf, Karen [1 ,5 ]
Haines, Krista [1 ,2 ,3 ]
Agarwal, Suresh [1 ,2 ,3 ]
Kasotakis, George [1 ,2 ,3 ]
机构
[1] Duke Univ, Med Ctr, Durham, NC 27708 USA
[2] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA
[3] Duke Univ, Div Trauma Acute & Crit Care Surg, Med Ctr, Durham, NC 27708 USA
[4] Duke Univ, Med Ctr, Div Urol, Durham, NC USA
[5] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[6] Duke Clin Res Inst, Durham, NC USA
关键词
NF-KAPPA-B; RESPIRATORY-DISTRESS-SYNDROME; TOLL-LIKE RECEPTORS; POSTTRANSCRIPTIONAL REGULATION; SIGNAL-TRANSDUCTION; EXPRESSION; INTERLEUKIN-10; INHIBITION; LIPOPOLYSACCHARIDE; PATTERN;
D O I
10.1371/journal.pone.0245169
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction Anti-inflammatory cytokine IL-10 suppresses pro-inflammatory IL-12b expression after Lipopolysaccharide (LPS) stimulation in colonic macrophages, as part of the innate immunity Toll-Like Receptor (TLR)-NF-kappa B activation system. This homeostatic mechanism limits excess inflammation in the intestinal mucosa, as it constantly interacts with the gut flora. This effect is reversed with Histone Deacetylase 3 (HDAC3), a class I HDAC, siRNA, suggesting it is mediated through HDAC3. Given alveolar macrophages' prominent role in Acute Lung Injury (ALI), we aim to determine whether a similar regulatory mechanism exists in the typically sterile pulmonary microenvironment. Methods Levels of mRNA and protein for IL-10, and IL-12b were determined by qPCR and ELISA/Western Blot respectively in naive and LPS-stimulated alveolar macrophages. Expression of the NF-kappa B intermediaries was also similarly assessed. Experiments were repeated with AS101 (an IL-10 protein synthesis inhibitor), MS-275 (a selective class 1 HDAC inhibitor), or both. Results LPS stimulation upregulated all proinflammatory mediators assayed in this study. In the presence of LPS, inhibition of IL-10 and/or class 1 HDACs resulted in both synergistic and independent effects on these signaling molecules. Quantitative reverse-transcriptase PCR on key components of the TLR4 signaling cascade demonstrated significant diversity in IL-10 and related gene expression in the presence of LPS. Inhibition of IL-10 secretion and/or class 1 HDACs in the presence of LPS independently affected the transcription of MyD88, IRAK1, Rela and the NF-kappa B p50 subunit. Interestingly, by quantitative ELISA inhibition of IL-10 secretion and/or class 1 HDACs in the presence of LPS independently affected the secretion of not only IL-10, IL-12b, and TNF alpha, but also proinflammatory mediators CXCL2, IL-6, and MIF. These results suggest that IL-10 and class 1 HDAC activity regulate both independent and synergistic mechanisms of proinflammatory cytokine/chemokine signaling. Conclusions Alveolar macrophages after inflammatory stimulation upregulate both IL-10 and IL-12b production, in a highly class 1 HDAC-dependent manner. Class 1 HDACs appear to help maintain the balance between the pro- and anti-inflammatory IL-12b and IL-10 respectively. Class 1 HDACs may be considered as targets for the macrophage-initiated pulmonary inflammation in ALI in a preclinical setting.
引用
收藏
页数:20
相关论文
共 66 条
[1]   TLR4 mutations are associated with endotoxin hyporesponsiveness in humans [J].
Arbour, NC ;
Lorenz, E ;
Schutte, BC ;
Zabner, J ;
Kline, JN ;
Jones, M ;
Frees, K ;
Watt, JL ;
Schwartz, DA .
NATURE GENETICS, 2000, 25 (02) :187-+
[2]   The p65 (RelA) subunit of NF-κB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression [J].
Ashburner, BP ;
Westerheide, SD ;
Baldwin, AS .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (20) :7065-7077
[3]  
Aste-Amezaga M, 1998, J IMMUNOL, V160, P5936
[4]   MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists [J].
Bagchi, Aranya ;
Herrup, Elizabeth A. ;
Warren, H. Shaw ;
Trigilio, James ;
Shin, Hae-Sook ;
Valentine, Catherine ;
Hellman, Judith .
JOURNAL OF IMMUNOLOGY, 2007, 178 (02) :1164-1171
[5]   Nucleic acids of mammalian origin can act as endogenous ligands for toll-like receptors and may promote systemic lupus erythematosus [J].
Barrat, FJ ;
Meeker, T ;
Gregorio, J ;
Chan, JH ;
Uematsu, S ;
Akira, S ;
Chang, B ;
Duramad, O ;
Coffman, RL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (08) :1131-1139
[6]   Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries [J].
Bellani, Giacomo ;
Laffey, John G. ;
Pham, Tai ;
Fan, Eddy ;
Brochard, Laurent ;
Esteban, Andres ;
Gattinoni, Luciano ;
van Haren, Frank ;
Larsson, Anders ;
McAuley, Daniel F. ;
Ranieri, Marco ;
Rubenfeld, Gordon ;
Thompson, B. Taylor ;
Wrigge, Hermann ;
Slutsky, Arthur S. ;
Pesenti, Antonio .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (08) :788-800
[7]   HIGH-DOSE CORTICOSTEROIDS IN PATIENTS WITH THE ADULT RESPIRATORY-DISTRESS SYNDROME [J].
BERNARD, GR ;
LUCE, JM ;
SPRUNG, CL ;
RINALDO, JE ;
TATE, RM ;
SIBBALD, WJ ;
KARIMAN, K ;
HIGGINS, S ;
BRADLEY, R ;
METZ, CA ;
HARRIS, TR ;
BRIGHAM, KL .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (25) :1565-1570
[8]   Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease [J].
Bradner, James E. ;
Mak, Raymond ;
Tanguturi, Shyam K. ;
Mazitschek, Ralph ;
Haggarty, Stephen J. ;
Ross, Kenneth ;
Chang, Cindy Y. ;
Bosco, Jocelyn ;
West, Nathan ;
Morse, Elizabeth ;
Lin, Katherine ;
Shen, John Paul ;
Kwiatkowski, Nicholas P. ;
Gheldof, Nele ;
Dekker, Job ;
DeAngelo, Daniel J. ;
Carr, Steven A. ;
Schreiber, Stuart L. ;
Golub, Todd R. ;
Ebert, Benjamin L. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (28) :12617-12622
[9]   The synthetic tellurium compound, AS101, is a novel inhibitor of IL-1β converting enzyme [J].
Brodsky, Miri ;
Yosef, Sigal ;
Galit, Rushkin ;
Albeck, Michael ;
Longo, Dan L. ;
Albeck, Amnon ;
Sredni, Benjamin .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2007, 27 (06) :453-462
[10]   MACROPHAGE IS AN IMPORTANT AND PREVIOUSLY UNRECOGNIZED SOURCE OF MACROPHAGE-MIGRATION INHIBITORY FACTOR [J].
CALANDRA, T ;
BERNHAGEN, J ;
MITCHELL, RA ;
BUCALA, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (06) :1895-1902